Therapeutic effect of low-molecular weight heparin and incidence of lower limb deep venous thrombosis and pulmonary embolism after laparoscopic bariatric surgery

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques

Volumn 23, Issue 6, 2013, Pages 491-493

  Khoursheed, Mousa ^a   Al Bader, Ibtisam ^a   Al Asfar, Fahad ^a   Sayed, Ali ^a   Al Mozaini, Abdulaziz ^b   Marouf, Rajaa ^b   Fingerhut, Abe ^c  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MUBARAK AL KABEER HOSPITAL   (Kuwait)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

gastric bypass; laparoscopy; venous thrombosis

Indexed keywords

ENOXAPARIN;

ADOLESCENT; ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; LAPAROSCOPIC SURGERY; LEG THROMBOSIS; LUNG EMBOLISM; MALE; MIDDLE AGED; OPERATION DURATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH BYPASS; THERAPY EFFECT; YOUNG ADULT;

ADOLESCENT; ADULT; ANASTOMOSIS, ROUX-EN-Y; BARIATRIC SURGERY; ENOXAPARIN; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LAPAROSCOPY; LEG; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS;

EID: 84890610496     PISSN: 15304515     EISSN: 15344908     Source Type: Journal    
DOI: 10.1097/SLE.0b013e31828e3c92     Document Type: Article

References (25)

1. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based, cohort study. Arch Intern Med. 1998;158:585-593.
2. Geertes WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: THE Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(suppl):338S-400S.
3. Stroh C, Luderer D, Weiner R, et al. Actual situation of thromboembolic prophylaxis in obesity surgery: data of quality assurance an bariatric surgery in Germany. Thrombosis. 2012;2012:209052.
4. Finks JF, English WJ, Carlin AM, et al. Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Ann Surg. 2012;255:1100-1104.
5. Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg. 2000;10:7-14.
6. Hammerstingl C. Monitoring therapeutic anticoagulation with low molecular weight heparins: is it useful or misleading? Cardiovasc Hematol Agents Med Chem. 2008;6:282-286.
7. Rowan B, Kuhl R, Lee M, et al. Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin. Obes Surg. 2008;18:162-166.
8. Brasileiro AL, Miranda F Jr, Ettinger JE, et al. Incidence of lower limbs deep vein thrombosis after open and laparoscopic gastric bypass: a prospective study. Obes Surg. 2008;18:52-57.
9. Wagenvoord RJ, Hendrixa HH, Koldeb HJ, et al. Development of a rapid and sensitive chromogenic heparin assay for clinical use. Haemostasis. 1993;23:26-37.
10. Simone EP, Madan AK, Tichansky DS, et al. Comparison of two low0-molecular-weight heparin dosing regimen for patients undergoing laparoscopic bariatric surgery. Surg Endosc. 2008;22:2392-2395.
11. Hebbeler SL, Marciniak CM, Crandall S, et al. Daily vs. twice daily enoxaparin in the prevention of venous thromboembolic disorders during rehabilitation following spinal cord injury. J Spin Cord Med. 2004;27:236-240.
12. Rowan BO, Kuhl DA, Lee MD, et al. Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin. Obes Surg. 2008;18:162-166.
13. Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis and VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15:1368-1374.
14. Leri F, Voyce SJ, Scialla S, et al. Enoxaparin dosing in the elderly using adjusted body weight. J Thromb Thrombolysis. 2009;28:348-353.
15. Barras MA, Duffull SB, Atherton JJ, et al. Individualized compared with conventional dosing of enoxaparin. Clin Pharmacol Ther. 2008;83:882-888.
16. Rondina MT, Wheeler M, Rodger GM, et al. Weightbased dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients. Thromb Res. 2010;125: 220-223.
17. Catheline JM, Turner R, Gaillard JL, et al. Thromboembolism in laparoscopic surgery: risk factors and preventive measures. Surg Laparosc Endosc Percutan Tech. 1999;9:135-139.
18. Kearon C. Noninvasive diagnosis of deep vein thrombosis in postoperative patients. Semin Thromb Hemost. 2001;27: 3-8.
19. Kearon C, Julian JA, Newman TE, et al. Non invasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med. 1998; 128:663-677.
20. Forbes K, Stevenson AJ. The use of power Doppler ultrasound in the diagnosis of isolated deep venous thrombosis of the calf. Clin Radiol. 1998;53:752-754.
21. Borkgren-Okonek MJ, Hart RW, Pantano JE, et al. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity. Surg Obes Relat Dis. 2008;4:625-631.
22. Nguyen NT, Owings JT, Gosselin R, et al. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg. 2001;136:909-916.
23. Gonzalez QH, Tishler DS, Plata-Munoz JJ, et al. Incidence of clinically evident deep venous thrombosis after laparoscopic Rou-en-Y gastric bypass. Surg Endosc. 2004;18:1082-1084.
24. Paige JT, Gouda BP, Gaitor-Stampley V, et al. No correlation between anti-factor Xa levels, low-molecular-weight heparin, and bleeding after gastric bypass. Surg Obes Relat Dis. 2007; 3:469-475.
25. Gonzalez R, Haines K, Nelson LG, et al. Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:30-36.